Reply: Challenging the TAVR-Centric Approach in Asymptomatic Severe AS. [PDF]
Dayan V, Bhatt DL.
europepmc +1 more source
Clinical Trial Safety Surveillance in Africa: Experts' Perspectives on Current Practices and Opportunities. [PDF]
Ejekam CS +4 more
europepmc +1 more source
Evaluation of the first standardized registry of approved research studies by the research ethics committees in Ecuador. [PDF]
Simbaña-Rivera K +3 more
europepmc +1 more source
Managing Refractory Pericarditis in the Era of Biologic Therapy: A Cardio-Oncology-Based Risk Framework. [PDF]
Bhalla JS, Saraswati U, Klein AL.
europepmc +1 more source
Can calcified plaque guide effective revascularization strategies? [PDF]
Shaw LJ, Patel KK, Bhatt DL.
europepmc +1 more source
Reply: Powering Evidence and Bridging Gaps on South Asian and African Enrollment in Cardiovascular RCTs. [PDF]
Uppal N +3 more
europepmc +1 more source
How would Marie Kondo design a protocol? In favor of subtractive change in clinical trials. [PDF]
Bender Ignacio R, Rowan K, Cook D.
europepmc +1 more source
Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections. [PDF]
Howard-Anderson J +15 more
europepmc +1 more source
Oxytocin substitution therapy in patients with AVP deficiency (central diabetes insipidus): study protocol of a double-blind, randomised placebo-controlled trial. [PDF]
Atila C +6 more
europepmc +1 more source
Toward a framework for psychedelic clinical trials in adolescents. [PDF]
Moore CK +3 more
europepmc +1 more source

